|
Volumn 26, Issue 10-12, 2007, Pages 1427-1430
|
Survivin mRNA antagonists using locked nucleic acid, potential for molecular cancer therapy
|
Author keywords
Antisense; LNA; Locked nucleic acid; mRNA; Survivin
|
Indexed keywords
COMPLEMENTARY RNA;
LOCKED NUCLEIC ACID;
MESSENGER RNA;
PACLITAXEL;
PROTEIN INHIBITOR;
SPC 2764;
SPC 3042;
SURVIVIN;
UNCLASSIFIED DRUG;
APOPTOSIS;
ARTICLE;
CANCER CELL CULTURE;
DRUG EFFECT;
DRUG POTENTIATION;
HUMAN;
HUMAN CELL;
IN VIVO STUDY;
PROTEIN EXPRESSION;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
HUMANS;
MALE;
MICROTUBULE-ASSOCIATED PROTEINS;
NEOPLASM PROTEINS;
OLIGONUCLEOTIDES;
PROSTATIC NEOPLASMS;
RNA, ANTISENSE;
RNA, MESSENGER;
|
EID: 36949022264
PISSN: 15257770
EISSN: 15322335
Source Type: Journal
DOI: 10.1080/15257770701542132 Document Type: Article |
Times cited : (12)
|
References (5)
|